Syngenta Group Q1 2025 EBITDA up 18% at $1.4 billion
Robust Crop Protection sales performance during the quarter as channel destocking ends and driven by growth in new crop protection technologies; continued strong growth in China
Robust Crop Protection sales performance during the quarter as channel destocking ends and driven by growth in new crop protection technologies; continued strong growth in China
Castrol India has reported total income of Rs. 1,454.24 crores during the period ended March 31, 2025
The company has posted net profit of Rs. 218.91 crores for the Financial Year ended March 31, 2025
The company reported consolidated EBITDA, excluding non-recurring & exceptional items, of Rs. 845 crore in FY25
The company reported Q4 FY24-25 PAT at Rs. 578 crore as against Rs. 164 crore for the quarter ended March 2024
The company has posted net profit of Rs. 434.60 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 1,444 crores for the Financial Year ended March 31, 2025
TANFAC has reported total income of Rs. 172.66 crores during the period ended March 31, 2025
Investment demonstrates confidence in America’s commitment to science and innovation
New TPU material series optimized for supercritical fluid (SCF) injection foaming technology
In Q4 FY25, CNG stations network reach to 647 CNG stations across 34 GAs
Sugarcane farmers will benefit from advanced agronomic practices, balanced crop nutrition, and direct access to markets
India Glycols receives EIR from USFDA for Dehradun plant
Jayshree Chemicals has reported total income of Rs. 4.42 crores during the period ended March 31, 2025
Bhansali Engineering Polymers has reported total income of Rs. 352.61 crores during the period ended March 31, 2025
IGL has reported total income of Rs. 4,431.11 crores during the period ended March 31, 2025
Cost reductions on track and continuous improvements through portfolio optimization
Chemicals adjusted pre-tax income increased mainly due to higher volumes and lower costs
The Group has commenced contingency measures to deliver EUR 20 million in annualised cost savings as a measure of prudence given the ongoing uncertainty.
IMCD’s consistent strategy and resilient business model has led to successful expansion over the years
Subscribe To Our Newsletter & Stay Updated